-
Post date
October 4, 2023
-
Posted by
Chris Parry
-
Posted in
Adastra Holdings, addiction, Beverages, Biotech, Cannabis, CBDs, Cocaine, drug delivery, fentanyl, Health Science, LSD, marijuana, medication, MedTech, Parry, PHRX.C, PMD.NYSE, psilocybin, Psychedelics, Psychemedics, research, Safe Supply Streaming, shrooms, SPLY.C, THC Biomed (THC.C), Today's Idea, Wellness, XTRX.C
-
Post date
June 29, 2022
-
Posted by
Kieran Robertson
-
Posted in
Ecstasy, Health Canada approval, Health Canada restricted drug amendments, Mushrooms, OPTI.C, Optimi, Optimi Health, Optimi Health Corp., psilocybin, psychedelic assisted therapy, psychedelic drug market, Psychedelics, SABI Mind, SAP, Special Access Program
-
Post date
June 29, 2022
-
Posted by
Kieran Robertson
-
Posted in
Ecstasy, Health Canada approval, Health Canada restricted drug amendments, Mushrooms, OPTI.C, Optimi, Optimi Health, Optimi Health Corp., psilocybin, psychedelic assisted therapy, psychedelic drug market, Psychedelics, SABI Mind, SAP, Special Access Program
-
Post date
February 17, 2022
-
Posted by
Vishal Toora
-
Posted in
2022 psychedelics stocks, best psychedelic stock, Cannabis, investments, LSD, MindMEd, money, Mushrooms, MYCO.NEO, PSIL, Psychedelic Stocks, Psychedelics, PSYK, Shroom, shroom-stocks, stock markets, stocks, Today's Analysis
-
Post date
February 11, 2022
-
Posted by
GaalenEngen
-
Posted in
can the metaverse help with psychotherapy, Health Science, LSD, Metaverse and mental health, Mushrooms, Psychedelics, Sector Roundup, what are some of the psychedelics stocks in 2022, what are the issues with the metaverse, who is taking mental health to the metaverse